Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Overexpression of the aryl hydrocarbon receptor in frontal fibrosing alopecia and lichen planopilaris: a potential pathogenic role for dioxins?: an investigational study of 38 patients.

Doche I, Pagliari C, Hordinsky MK, Wilcox GL, Rivitti-Machado MCM, Romiti R, Valente NYS, Shaik JA, Saldanha M, Sotto MN.

J Eur Acad Dermatol Venereol. 2020 Feb 11. doi: 10.1111/jdv.16287. [Epub ahead of print] No abstract available.

PMID:
32043632
2.

Defining and Managing Pain in Stroke and Traumatic Brain Injury Research.

Larson CM, Wilcox GL, Fairbanks CA.

Comp Med. 2019 Dec 1;69(6):510-519. doi: 10.30802/AALAS-CM-19-000099. Epub 2019 Dec 20.

PMID:
31896392
3.

The Study of Pain in Rats and Mice.

Larson CM, Wilcox GL, Fairbanks CA.

Comp Med. 2019 Dec 1;69(6):555-570. doi: 10.30802/AALAS-CM-19-000062. Epub 2019 Dec 10.

PMID:
31822322
4.

Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.

Bruce DJ, Peterson CD, Kitto KF, Akgün E, Lazzaroni S, Portoghese PS, Fairbanks CA, Wilcox GL.

Anesthesiology. 2019 Sep;131(3):649-663. doi: 10.1097/ALN.0000000000002840.

PMID:
31343460
5.

Interleukin-8 as a therapeutic target for chronic low back pain: Upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model.

Krock E, Millecamps M, Anderson KM, Srivastava A, Reihsen TE, Hari P, Sun YR, Jang SH, Wilcox GL, Belani KG, Beebe DS, Ouellet J, Pinto MR, Kehl LJ, Haglund L, Stone LS.

EBioMedicine. 2019 May;43:487-500. doi: 10.1016/j.ebiom.2019.04.032. Epub 2019 Apr 30.

6.

AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection.

Peterson CD, Skorput AGJ, Kitto KF, Wilcox GL, Vulchanova L, Fairbanks CA.

Methods Mol Biol. 2019;1950:199-207. doi: 10.1007/978-1-4939-9139-6_11.

PMID:
30783975
7.

Detailed Method for Intrathecal Delivery of Gene Therapeutics by Direct Lumbar Puncture in Mice.

Pflepsen KR, Peterson CD, Kitto KF, Vulchanova L, Wilcox GL, Fairbanks CA.

Methods Mol Biol. 2019;1937:305-312. doi: 10.1007/978-1-4939-9065-8_20.

PMID:
30706406
8.

Agmatine preferentially antagonizes GluN2B-containing N-methyl-d-aspartate receptors in spinal cord.

Waataja JJ, Peterson CD, Verma H, Goracke-Postle CJ, Séguéla P, Delpire E, Wilcox GL, Fairbanks CA.

J Neurophysiol. 2019 Feb 1;121(2):662-671. doi: 10.1152/jn.00172.2018. Epub 2018 Nov 14.

9.

Evidence for neurogenic inflammation in lichen planopilaris and frontal fibrosing alopecia pathogenic mechanism.

Doche I, Wilcox GL, Ericson M, Valente NS, Romiti R, McAdams BD, Hordinsky MK.

Exp Dermatol. 2020 Mar;29(3):282-285. doi: 10.1111/exd.13835. Epub 2019 Feb 12.

PMID:
30408256
10.

Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice.

Peterson CD, Kitto KF, Akgün E, Lunzer MM, Riedl MS, Vulchanova L, Wilcox GL, Portoghese PS, Fairbanks CA.

Pain. 2017 Dec;158(12):2431-2441. doi: 10.1097/j.pain.0000000000001050.

11.

A Case-Controlled Investigation of Tactile Reactivity in Young Children With and Without Global Developmental Delay.

Barney CC, Tervo R, Wilcox GL, Symons FJ.

Am J Intellect Dev Disabil. 2017 Sep;122(5):409-421. doi: 10.1352/1944-7558-122.5.409.

PMID:
28846038
12.

Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.

Lim TKY, Anderson KM, Hari P, Di Falco M, Reihsen TE, Wilcox GL, Belani KG, LaBoissiere S, Pinto MR, Beebe DS, Kehl LJ, Stone LS.

J Pain. 2017 Oct;18(10):1253-1269. doi: 10.1016/j.jpain.2017.06.002. Epub 2017 Jun 24.

13.

In vivo optogenetic activation of Nav1.8+ cutaneous nociceptors and their responses to natural stimuli.

Uhelski ML, Bruce DJ, Séguéla P, Wilcox GL, Simone DA.

J Neurophysiol. 2017 Jun 1;117(6):2218-2223. doi: 10.1152/jn.00083.2017. Epub 2017 Mar 15.

14.

A case-controlled comparison of postoperative analgesic dosing between girls with Rett syndrome and girls with and without developmental disability undergoing spinal fusion surgery.

Barney CC, Merbler AM, Quest K, Byiers BJ, Wilcox GL, Schwantes S, Roiko SA, Feyma T, Beisang A, Symons FJ.

Paediatr Anaesth. 2017 Mar;27(3):290-299. doi: 10.1111/pan.13066. Epub 2017 Feb 8.

15.

Substance P in keratosis follicularis spinulosa decalvans.

Doche I, Hordinsky M, Wilcox GL, Valente NS, Romiti R.

JAAD Case Rep. 2015 Sep 20;1(6):327-8. doi: 10.1016/j.jdcr.2015.08.001. eCollection 2015 Nov. No abstract available.

16.

Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Chabot-Doré AJ, Millecamps M, Naso L, Devost D, Trieu P, Piltonen M, Diatchenko L, Fairbanks CA, Wilcox GL, Hébert TE, Stone LS.

Neuropharmacology. 2015 Dec;99:285-300. doi: 10.1016/j.neuropharm.2015.08.010. Epub 2015 Aug 6.

17.

The Subjective Experience of Pain: An FMRI Study of Percept-Related Models and Functional Connectivity.

Wilcox CE, Mayer AR, Teshiba TM, Ling J, Smith BW, Wilcox GL, Mullins PG.

Pain Med. 2015 Nov;16(11):2121-33. doi: 10.1111/pme.12785. Epub 2015 May 19.

18.

Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects.

Stone LS, German JP, Kitto KF, Fairbanks CA, Wilcox GL.

PLoS One. 2014 Oct 9;9(10):e109903. doi: 10.1371/journal.pone.0109903. eCollection 2014.

19.

Can biomarkers differentiate pain and no pain subgroups of nonverbal children with cerebral palsy? A preliminary investigation based on noninvasive saliva sampling.

Symons FJ, ElGhazi I, Reilly BG, Barney CC, Hanson L, Panoskaltsis-Mortari A, Armitage IM, Wilcox GL.

Pain Med. 2015 Feb;16(2):249-56. doi: 10.1111/pme.12545. Epub 2014 Sep 19.

20.

Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.

Schuster DJ, Metcalf MD, Kitto KF, Messing RO, Fairbanks CA, Wilcox GL.

Br J Pharmacol. 2015 Jan;172(2):642-53. doi: 10.1111/bph.12774. Epub 2014 Nov 24.

21.

Analgesic synergy between opioid and α2 -adrenoceptors.

Chabot-Doré AJ, Schuster DJ, Stone LS, Wilcox GL.

Br J Pharmacol. 2015 Jan;172(2):388-402. doi: 10.1111/bph.12695. Epub 2014 Jul 1. Review.

22.

Effect of chronic pain on fentanyl self-administration in mice.

Wade CL, Krumenacher P, Kitto KF, Peterson CD, Wilcox GL, Fairbanks CA.

PLoS One. 2013 Nov 15;8(11):e79239. doi: 10.1371/journal.pone.0079239. eCollection 2013.

23.

Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.

Schuster DJ, Kitto KF, Overland AC, Messing RO, Stone LS, Fairbanks CA, Wilcox GL.

J Neurosci. 2013 Aug 14;33(33):13538-46. doi: 10.1523/JNEUROSCI.4013-12.2013.

24.

The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.

Metcalf MD, Yekkirala AS, Powers MD, Kitto KF, Fairbanks CA, Wilcox GL, Portoghese PS.

ACS Chem Neurosci. 2012 Jul 18;3(7):505-9. doi: 10.1021/cn3000394. Epub 2012 May 22.

25.

Mechanism of cancer pain.

Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL.

Mol Interv. 2010 Jun;10(3):164-78. doi: 10.1124/mi.10.3.7. Review.

26.

Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture.

Vulchanova L, Schuster DJ, Belur LR, Riedl MS, Podetz-Pedersen KM, Kitto KF, Wilcox GL, McIvor RS, Fairbanks CA.

Mol Pain. 2010 May 28;6:31. doi: 10.1186/1744-8069-6-31.

27.

Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine.

El Ghazi I, Sheng WS, Hu S, Reilly BG, Lokensgard JR, Rock RB, Peterson PK, Wilcox GL, Armitage IM.

J Neuroimmune Pharmacol. 2010 Dec;5(4):574-81. doi: 10.1007/s11481-010-9197-8. Epub 2010 Mar 25.

28.

Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord.

Overland AC, Kitto KF, Chabot-Doré AJ, Rothwell PE, Fairbanks CA, Stone LS, Wilcox GL.

J Neurosci. 2009 Oct 21;29(42):13264-73. doi: 10.1523/JNEUROSCI.1907-09.2009.

29.

Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Fairbanks CA, Stone LS, Wilcox GL.

Pharmacol Ther. 2009 Aug;123(2):224-38. doi: 10.1016/j.pharmthera.2009.04.001. Epub 2009 Apr 23. Review.

30.

Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord.

Fairbanks CA, Kitto KF, Nguyen HO, Stone LS, Wilcox GL.

Anesthesiology. 2009 Mar;110(3):638-47. doi: 10.1097/ALN.0b013e318195b51d.

31.

Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn.

Riedl MS, Schnell SA, Overland AC, Chabot-Doré AJ, Taylor AM, Ribeiro-da-Silva A, Elde RP, Wilcox GL, Stone LS.

J Comp Neurol. 2009 Apr 1;513(4):385-98. doi: 10.1002/cne.21982. Erratum in: J Comp Neurol. 2009 Jun 20;514(6):674.

32.

Peripheral mechanisms of pain and analgesia.

Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, Overland AC, Vanderah TW, Spencer RH.

Brain Res Rev. 2009 Apr;60(1):90-113. doi: 10.1016/j.brainresrev.2008.12.017. Epub 2008 Dec 31. Review.

33.

Activation of spinal microglia in a murine model of peripheral inflammation-induced, long-lasting contralateral allodynia.

Schreiber KL, Beitz AJ, Wilcox GL.

Neurosci Lett. 2008 Jul 25;440(1):63-7. doi: 10.1016/j.neulet.2008.05.044. Epub 2008 May 17.

34.
35.

The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception.

Vit JP, Ohara PT, Tien DA, Fike JR, Eikmeier L, Beitz A, Wilcox GL, Jasmin L.

Pain. 2006 Jan;120(1-2):188-201. Epub 2005 Dec 19.

PMID:
16360279
36.

Tumor-induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors.

Wacnik PW, Baker CM, Herron MJ, Kren BT, Blazar BR, Wilcox GL, Hordinsky MK, Beitz AJ, Ericson ME.

Pain. 2005 May;115(1-2):95-106.

PMID:
15836973
37.

Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice.

Wacnik PW, Eikmeier LJ, Simone DA, Wilcox GL, Beitz AJ.

Neuroscience. 2005;132(2):479-91.

PMID:
15802198
38.

Alpha-2-adrenergic and opioid receptor additivity in rat locus coeruleus neurons.

Stone LS, Wilcox GL.

Neurosci Lett. 2004 May 6;361(1-3):265-8.

PMID:
15135944
39.

Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord.

Stone LS, Vulchanova L, Riedl MS, Williams FG, Wilcox GL, Elde R.

Neurosci Lett. 2004 May 6;361(1-3):208-11.

PMID:
15135930
40.

Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse.

Cain DM, Wacnik PW, Eikmeier L, Beitz A, Wilcox GL, Simone DA.

Pain Med. 2001 Mar;2(1):15-23.

PMID:
15102313
41.

Analgesic effects of a soy-containing diet in three murine bone cancer pain models.

Zhao C, Wacnik PW, Tall JM, Johns DC, Wilcox GL, Meyer RA, Raja SN.

J Pain. 2004 Mar;5(2):104-10.

PMID:
15042518
42.
43.
44.

A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain.

Kehl LJ, Hamamoto DT, Wacnik PW, Croft DL, Norsted BD, Wilcox GL, Simone DA.

Pain. 2003 May;103(1-2):175-86.

PMID:
12749972
45.

Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan.

Wacnik PW, Kehl LJ, Trempe TM, Ramnaraine ML, Beitz AJ, Wilcox GL.

Pain. 2003 Jan;101(1-2):175-86.

PMID:
12507712
46.

Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception.

Laughlin TM, Tram KV, Wilcox GL, Birnbaum AK.

J Pharmacol Exp Ther. 2002 Sep;302(3):1168-75.

PMID:
12183677
47.

alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy.

Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL.

J Pharmacol Exp Ther. 2002 Jan;300(1):282-90.

PMID:
11752127
48.

Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain.

Cain DM, Wacnik PW, Turner M, Wendelschafer-Crabb G, Kennedy WR, Wilcox GL, Simone DA.

J Neurosci. 2001 Dec 1;21(23):9367-76.

49.

Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Wacnik PW, Eikmeier LJ, Ruggles TR, Ramnaraine ML, Walcheck BK, Beitz AJ, Wilcox GL.

J Neurosci. 2001 Dec 1;21(23):9355-66.

50.

Mechanisms of induction of persistent nociception by dynorphin.

Laughlin TM, Larson AA, Wilcox GL.

J Pharmacol Exp Ther. 2001 Oct;299(1):6-11. Review.

PMID:
11561057

Supplemental Content

Loading ...
Support Center